After 20 years of high-profile failure, gene therapy is finally well on its way to clinical approval.
After 20 years of high-profile failure, gene therapy is finally well on its way to clinical approval.
Revising a dysfunctional gene in vivo for the first time, researchers successfully restore blood clotting in hemophiliac mice.
Page 1 of 1